Being at the heart of pharma and along with the business on the showfloor, The CPHI & PMEC India Expo transcended its core, melding seamlessly with the prestigious ‘India Pharma Week’, a curated series of events meeting every requirement of the pharma professional. These included the Pharma Leaders Golf; Pre-Connect Congress; Pharma Leaders Roundtable; Women in Pharma; Pharma Talks; and India Pharma Awards, ushering in a select gathering of leaders of distinction and eminence. The closed-door Pharma Leaders’ Roundtable underscored the critical importance of directing attention toward both incremental and revolutionary innovation. Noteworthy strategic discussions unfolded, encompassing the elevation of cost efficiency and the embrace of digital transformation to optimize operations and curtail expenses.

The imperative to address the innovation funding gap emerged, with a call for strategic alliances with academia, biotech entities, and venture capital firms. Another pivotal theme was the establishment of innovation clusters, envisioned to nurture collaboration and facilitate the exchange of knowledge. A White paper report taking in the key tenets of the recommendation is being prepared to be served to the power corridors.

Highlighting India’s promising position within the global market, Mr. Yogesh Mudras, Managing Director, Informa Markets in India said, “India has earned its way to becoming a pharma super power with over 200+ countries served by Indian pharma exports. And yet, obstacles remain with nearly 30% of Indians lacking access to medicines. We are truly at an inflection point where we are finding innovative ways for seamless Geographical distribution of pharmaceutical access of quality supply.

For 16 years, CPHI & PMEC India has been at the pulse of the pharma industry’s meteoric rise, evolving from a trade show to a global hub for innovation and collaboration. We proudly represent the world’s largest pharma community, fueling India’s domestic muscle, surging R&D, and government support. This remarkable growth is driven by cutting-edge technology, breakthrough drugs, and a patient-centric focus, positioning India as a major player in the global pharma landscape. CPHI & PMEC India remains dedicated to playing a vital role in India’s journey towards pharma excellence through its platforms enabling collaboration, knowledge sharing, and innovation,” he added.

Amidst the vibrant tapestry of the industry celebration at the expo, one of the eye-catching points of focus was the colossal cut-out replica of ‘India Gate’, reminding attendees that they were indeed at the ‘Heart of Pharma’, just as visitors pay homage to India Gate, revered as a national symbol, that is nestled in the heart of India, in New Delhi. As attendees ranging from influential leaders and seasoned experts to esteemed pharmaceutical executives, decision-makers, buyers, procurement managers, contract manufacturers, hospital administrators, representatives from National and State Regulatory Boards immersed themselves in the expo, the symbolic presence of the makeshift India Gate served as a powerful reminder, emphasizing the pivotal position of the expo at the very core of the pharmaceutical realm.